Home Metabolism CPT

CPT

Isoform-selective Products

CPT Products

  • All (5)
  • CPT Inhibitors (3)
  • CPT Activator (1)
  • CPT Agonist (1)
  • New CPT Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8244 Etomoxir sodium salt Etomoxir sodium salt ((R)-(+)-Etomoxir sodium salt) is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) on the outer face of the inner mitochondrial membrane. Etomoxir enhances palmitate-induced cell apoptosis.
Cell Death Discov, 2025, 11(1):21
Eur J Pharmacol, 2025, 991:177343
Bioact Mater, 2024, 35:549-563
S9819 C75 C75 (4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid) , a more stable synthetic mimic of cerulenin, inhibits fatty-acid synthase (FAS/FASN) with an IC50 of 15.53 μM and has potential therapeutic effects in several cancer models. C75 is also a potent CPT1A activator.
Adv Sci (Weinh), 2024, 11(46):e2401311
PLoS Pathog, 2024, 20(5):e1012228
PLoS Pathog, 2024, 20(5):e1012228
S6959 Perhexiline maleate Perhexiline maleate is a potent inhibitor of carnitine palmitoyltransferase 1 (CPT1) with IC50s of 77 μM and 148 μM for rat heart CPT1 and liver CPT1, respectively, and also inhibits carnitine palmitoyltransferase 2 (CPT2).
Cancer Cell, 2022, S1535-6108(22)00312-9
S2269 Baicalin Baicalin is an inhibitor of prolyl oligopeptidase and also is an allosteric activator of carnitine palmityl transferase 1 (CPT1). Baicalin reduces the expression of NF-κB.
Ecotoxicol Environ Saf, 2024, 275:116262
Chem Biol Interact, 2024, 387:110820
Int J Mol Sci, 2023, 24(11)9435
E4787New Etomoxir Etomoxir is an irreversible, small-molecule inhibitor of carnitine palmitoyl-transferase 1a (CPT1a). It inhibits fatty acid oxidation (FAO) and may have potential in treating diabetes, inflammation, cancer and cardiac metabolic diseases.
Mol Cancer, 2025, 24(1):34
Eur J Immunol, 2024, 54(7):e2250342
S8244 Etomoxir sodium salt Etomoxir sodium salt ((R)-(+)-Etomoxir sodium salt) is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) on the outer face of the inner mitochondrial membrane. Etomoxir enhances palmitate-induced cell apoptosis.
Cell Death Discov, 2025, 11(1):21
Eur J Pharmacol, 2025, 991:177343
Bioact Mater, 2024, 35:549-563
S6959 Perhexiline maleate Perhexiline maleate is a potent inhibitor of carnitine palmitoyltransferase 1 (CPT1) with IC50s of 77 μM and 148 μM for rat heart CPT1 and liver CPT1, respectively, and also inhibits carnitine palmitoyltransferase 2 (CPT2).
Cancer Cell, 2022, S1535-6108(22)00312-9
E4787New Etomoxir Etomoxir is an irreversible, small-molecule inhibitor of carnitine palmitoyl-transferase 1a (CPT1a). It inhibits fatty acid oxidation (FAO) and may have potential in treating diabetes, inflammation, cancer and cardiac metabolic diseases.
Mol Cancer, 2025, 24(1):34
Eur J Immunol, 2024, 54(7):e2250342
S2269 Baicalin Baicalin is an inhibitor of prolyl oligopeptidase and also is an allosteric activator of carnitine palmityl transferase 1 (CPT1). Baicalin reduces the expression of NF-κB.
Ecotoxicol Environ Saf, 2024, 275:116262
Chem Biol Interact, 2024, 387:110820
Int J Mol Sci, 2023, 24(11)9435
S9819 C75 C75 (4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid) , a more stable synthetic mimic of cerulenin, inhibits fatty-acid synthase (FAS/FASN) with an IC50 of 15.53 μM and has potential therapeutic effects in several cancer models. C75 is also a potent CPT1A activator.
Adv Sci (Weinh), 2024, 11(46):e2401311
PLoS Pathog, 2024, 20(5):e1012228
PLoS Pathog, 2024, 20(5):e1012228
E4787New Etomoxir Etomoxir is an irreversible, small-molecule inhibitor of carnitine palmitoyl-transferase 1a (CPT1a). It inhibits fatty acid oxidation (FAO) and may have potential in treating diabetes, inflammation, cancer and cardiac metabolic diseases.
Mol Cancer, 2025, 24(1):34
Eur J Immunol, 2024, 54(7):e2250342

Choose Selective CPT Inhibitors

Tags: CPT inhibitor|CPT agonist|CPT activator|CPT inducer|CPT antagonist|CPT signaling pathway|CPT assay kit